As LEF-1 is not expressed in the normal colon mucosa [13], but is found in human colorectal cancer [14], a shift of β-catenin binding partners from TCF4 to LEF-1 might occur during carcinogenesis which might enable enhanced epithelial-mesenchymal transition (EMT) and malignant progression. The gene discussed is LEF1; the disease is colorectal cancer.